Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
Sydney X. Lu, Emma De Neef, James D. Thomas, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 4032-4047.e31
Open Access | Times Cited: 214

Showing 1-25 of 214 citing articles:

Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 521
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 259
Rational combinations of targeted cancer therapies: background, advances and challenges
Haojie Jin, Liqin Wang, René Bernards
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 213-234
Closed Access | Times Cited: 249
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Malgorzata Ewa Rogalska, Claudia Vivori, Juan Valcárcel
Nature Reviews Genetics (2022) Vol. 24, Iss. 4, pp. 251-269
Closed Access | Times Cited: 133
Cellular pathways influenced by protein arginine methylation: Implications for cancer
Jian Xu, Stéphane Richard
Molecular Cell (2021) Vol. 81, Iss. 21, pp. 4357-4368
Open Access | Times Cited: 129
Arginine reprograms metabolism in liver cancer via RBM39
Dirk Mossmann, Christoph Müller, Sujin Park, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5068-5083.e23
Open Access | Times Cited: 116
Dysregulation and therapeutic targeting of RNA splicing in cancer
Robert Stanley, Omar Abdel‐Wahab
Nature Cancer (2022) Vol. 3, Iss. 5, pp. 536-546
Open Access | Times Cited: 105
Antibody–drug conjugates: Recent advances in payloads
Zhijia Wang, Hanxuan Li, Lantu Gou, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4025-4059
Open Access | Times Cited: 102
U1 snRNP increases RNA Pol II elongation rate to enable synthesis of long genes
Claudia A. Mimoso, Karen Adelman
Molecular Cell (2023) Vol. 83, Iss. 8, pp. 1264-1279.e10
Open Access | Times Cited: 56
PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity
Jing Liu, Xia Bu, Chen Chu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 43
Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells
Rui Ding, Xiaoyan Yu, Zhilin Hu, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 528-540.e6
Closed Access | Times Cited: 31
Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy
Guangyuan Li, Shweta Mahajan, Siyuan Ma, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 730
Open Access | Times Cited: 28
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Leveraging big data of immune checkpoint blockade response identifies novel potential targets
Yacine Barèche, Deirdre Kelly, Farnoosh Abbas‐Aghababazadeh, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1304-1317
Closed Access | Times Cited: 49
Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic
Jan Philipp Bewersdorf, Omar Abdel‐Wahab
Genes & Development (2022) Vol. 36, Iss. 5-6, pp. 259-277
Open Access | Times Cited: 40
The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Reversal of malignant ADAR1 splice isoform switching with Rebecsinib
Leslie Crews, Wenxue Ma, Luisa Ladel, et al.
Cell stem cell (2023) Vol. 30, Iss. 3, pp. 250-263.e6
Open Access | Times Cited: 36
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
Yunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104572-104572
Open Access | Times Cited: 32
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
DNA hydrogels and nanogels for diagnostics, therapeutics, and theragnostics of various cancers
Iman Zare, Reza Taheri‐Ledari, Farhad Esmailzadeh, et al.
Nanoscale (2023) Vol. 15, Iss. 26, pp. 10882-10903
Closed Access | Times Cited: 27
Pre-mRNA splicing-associated diseases and therapies
Sierra L. Love, Joseph D. Emerson, Kazunori Koide, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 525-538
Open Access | Times Cited: 26
Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer
Haonan Lu, Hantao Lou, Georg Wengert, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 7, pp. 101092-101092
Open Access | Times Cited: 25
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top